Ignite Creation Date:
2024-05-05 @ 9:17 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00853164
Status:
COMPLETED
Last Update Posted:
2018-05-07
First Post:
2009-02-27
Brief Title:
A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy ADT
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MAP-P
Brief Summary:
60 eligible subjects will be randomized into one of three study arms 1 aerobic exercise 2 resistance exercise or 3 usual care Baseline measurements will be done on all study subjects these measurements include height weight dual energy x-ray absorptiometry DXA for bone mineral density and lean body mass measurements blood will be taken to measure serum free testosterone prostate-specific antigen PSA glucose and insulin levels Fitness will also be evaluated using a graded exercise test Questionnaires on health and personal history will also be completed Men randomized to the aerobic exercise treatment arm will participate in a walking program three times a week for eight weeks The participants will start at 15 minutes per session and increase to a goal of 60 minutes per session Men randomized to the resistance training treatment arm will participate in an eight-week program of eight strength training exercises three times per week Men in the usual care arm will receive written materials from the American Cancer Society about coping with cancer which includes information about participation in physical activity At the end of the eight week intervention participants in all three study arms will complete the same questionnaires and measurements they completed at baseline
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None